sorbitol has been researched along with propofol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Buijs, EJ; van Zuylen, HJ | 1 |
| Babl, J; Doenicke, AW; Klotz, U; Kugler, J; O'Connor, M; Rau, J; Roizen, MF | 1 |
| Cox, EH; Danhof, M; Knibbe, CA; Koster, VS; Kuks, PF; Lange, R; Langemeijer, HJ; Langemeijer, MW; Lie-A-Huen, L; Tukker, EE | 1 |
| Aarts, LP; Danhof, M; Knibbe, CA; Kuks, PF; Naber, H | 1 |
| Aarts, LP; Boom, FA; Bras, LJ; Danhof, M; Knibbe, CA; Peeters, MY; Tibboel, D | 1 |
| Chaki, T; Hirata, N; Tachibana, S; Tokinaga, Y; Yamakage, M; Yoshikawa, Y | 1 |
| Chen, MS; Lin, WC; Lu, PK; Sheu, SM; Shin, HC; Sie, SR | 1 |
| Chen, HF; Chen, MS; Fang, CL; Lin, WC; Sheu, SM; Yang, KS | 1 |
1 review(s) available for sorbitol and propofol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for sorbitol and propofol
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of propofol in a new solvent.
Topics: Adult; Anesthetics, Intravenous; Chemistry, Pharmaceutical; Cross-Over Studies; Drug Combinations; Electroencephalography; Fat Emulsions, Intravenous; Humans; Injections, Intravenous; Male; Pain; Phospholipids; Propofol; Sleep; Sorbitol | 1997 |
Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Conscious Sedation; Critical Illness; Drug Combinations; Enteral Nutrition; Fat Emulsions, Intravenous; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Middle Aged; Phospholipids; Propofol; Prospective Studies; Respiration, Artificial; Sorbitol; Time Factors; Triglycerides | 2004 |
Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients.
Topics: Aged; Anesthetics; Cardiac Output; Critical Illness; Female; Humans; Liver; Male; Middle Aged; Nonlinear Dynamics; Pilot Projects; Propofol; Software; Sorbitol; Thermodilution | 2008 |
8 other study(ies) available for sorbitol and propofol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Metabolic consequences of a sorbitol overdose during neurosurgery.
Topics: Acidosis, Lactic; Adenosine Diphosphate; Adenosine Triphosphate; Anesthesia, General; Anesthetics, General; Blood Glucose; Dexamethasone; Diuretics, Osmotic; Drug Overdose; Electrolytes; Etomidate; Humans; Insulin; Insulin, Regular, Pork; Intracranial Aneurysm; Lactates; Male; Middle Aged; Neurosurgery; Phosphates; Propofol; Pseudotumor Cerebri; Sorbitol; Sufentanil; Uric Acid | 1997 |
Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol.
Topics: Anesthetics, Intravenous; Animals; Drug Combinations; Electroencephalography; Fat Emulsions, Intravenous; Infusions, Intravenous; Male; Models, Statistical; Phospholipids; Propofol; Rats; Rats, Wistar; Sorbitol; Statistics, Nonparametric | 1998 |
Lipid emulsion, but not propofol, induces skeletal muscle damage and lipid peroxidation.
Topics: Anesthetics, Intravenous; Animals; Antioxidants; Drug Combinations; Infusions, Intravenous; Lipid Peroxidation; Male; Malondialdehyde; Muscle, Skeletal; Phospholipids; Propofol; Rats; Rats, Wistar; Sorbitol | 2019 |
Lipofundin Mediates the Major Inhibition of Intravenous Propofol in IL-1β Secretion and Phagocytosis of Staphylococcus aureus-Infected Macrophages.
Topics: Administration, Intravenous; Animals; Down-Regulation; Drug Combinations; Gene Expression Regulation; Interleukin-1beta; Macrophages; Mice; Phagocytosis; Phospholipids; Propofol; RAW 264.7 Cells; Reactive Oxygen Species; Sorbitol; Staphylococcus aureus | 2020 |
Lipofundin mediates major inhibition of intravenous propofol on phorbol myristate acetate and Escherichia coli-induced neutrophil extracellular traps.
Topics: Administration, Intravenous; Drug Combinations; Emulsions; Escherichia coli; Extracellular Signal-Regulated MAP Kinases; Extracellular Traps; Humans; Hypochlorous Acid; Neutrophils; Phospholipids; Propofol; Reactive Oxygen Species; Solvents; Sorbitol; Tetradecanoylphorbol Acetate | 2022 |